Filters Filter
Cross PopUp
FILTER :

filter

01 Bioanalytical & Biomarker Testing Services

02 Bioequivalence / Clinical / Pre-Clinical Testing

03 Bioequivalence / Clinical / Pre-Clinical Testing

04 Calculation and Modeling of Pharmacokinetic Parameters

05 Calculation and Modeling of Pharmacokinetic Parameters

06 Capillary Electrophoresis

07 Immunoassay & Cell Based Assay

08 Method Development and Validation

09 Method Development and Validation

10 Overview

11 Overview

12 Overview

13 Protein Isolation, Identification and Characterization

14 Protein Isolation, Identification and Characterization

15 Proteomics

16 Proteomics

17 Quantitative Bioanalysis

18 Quantitative Bioanalysis

19 Radiometric Detection

20 Structural Characterization

21 Structural Characterization

filter

01 APC Ltd

02 Actarmo Medical

03 Aenova Group

04 Agilent Technologies

05 Aizant Drug Research Solutions Pvt. Ltd.

06 Analytical Resource Laboratories

07 Anthem Biosciences

08 Arcinova

09 Ardena

10 Azidus Laboratories

11 BioAgilytix

12 BioReliance

13 Biognosys

14 Bora Pharmaceuticals

15 CEDx Labs

16 Cambrex Corporation

17 Cambridge Biomedical Inc

18 Cayman Chemical Company Inc

19 Celerion

20 CellMosaic, Inc

21 Cliantha Research

22 Comparative Biosciences, Inc

23 Dalmia

24 Era Pharma Solutions

25 Eurofins BioPharma Services

26 Eurofins CDMO

27 Flagship Biotech International Pvt. Ltd

28 FumoPrep

29 GBI

30 Intertek Pharmaceutical Services

31 Jubilant HollisterStier

32 LabConnect

33 LakePharma

34 MPI Research Inc

35 Marin Biologic Laboratories

36 Merck Millipore

37 Nanjing Mingjie Biomedical Testing

38 Nutrasource

39 Nuvisan GmbH

40 PAREXEL International Corporation

41 PPD

42 Piramal Pharma Solutions

43 Proteome Sciences

44 QPS Bioserve India

45 QUINTA-ANALYTICA s.r.o

46 Quotient Sciences

47 Rusan Pharma

48 SEQUENT SCIENTIFIC LTD

49 SEQme

50 SGS Life Sciences

51 Sartorius Stedim Biotech

52 Shantani Proteome Analytics Pvt. Ltd

53 Solvias

54 Xcelris Genomics

55 Zelmic

56 deltaDOT

57 mKnal Global Solutions

filter

01 Belgium

02 Canada

03 China

04 Czech Republic

05 France

06 Germany

07 Hungary

08 India

09 India

10 Ireland

11 Sweden

12 Switzerland

13 Taiwan

14 Turkey

15 U.A.E

16 U.S.A

17 U.S.A

18 United Kingdom

19 United Kingdom

List of Learn MoreList of #LearnMore

Looking for bioanalytical contract services? Find a CRO offering contract bioanalytical testing and clinical bioanalysis services on PharmaCompass.

Q1. What are bioanalytical services?

Bioanalytical services encompass a diverse array of scientific methods and analyses utilized for the quantitative assessment and characterization of substances in biological matrices such as blood, tissue, serum, urine, or other body fluids. It enclose a suite of offerings available for researchers to engage with contract organizations possessing the necessary resources and expertise to conduct bioanalysis. It also involves the quantitative measurement of xenobiotics, including drugs, metabolites, and endogenous biomolecules along with the analysis of biotics such as biomarkers, proteins, DNA, and large molecule drugs within biological systems.

Bioanalytical services typically comprise of sample preparation, bioanalytical method development and validation, lead optimization, bioavailability and bioequivalence studies, pharmacokinetic analysis, and dose formulation analysis. Apart from this it also covers biomarker testing services, cell-based assays, proteomics, quantitative bioanalysis, pre-clinical examinations, testing of fluids or specimens, bioanalysis of clinical samples, and investigation of viral infections within the body, among other tasks.

As new drug molecule research is becoming more intricate and the demand for personalized medicine rises, the bioanalytical services market is witnessing substantial expansion. Thus, bioanalytical studies play a crucial role in drug discovery and development as the data derived from these studies are essential for defining the properties of prospective new biological molecules.

Various CRO for bioanalytical services and bioanalytical contract service provider offers bioanalytical solutions from preclinical to clinical and commercial scales. These contract research organizations are well equipped with the necessary facilities and technologies to offer bioanalytical contract services such as bioanalytical testing, bioanalytical method development and validation, biosimilar and biomarker analysis, etc.

Q2. What are the various bioanalytical testing services?

Bioanalytical testing services encompass a range of laboratory examinations performed on biological samples to quantify drug levels and biomarkers. These services are integral to the drug development journey, offering essential data on pharmacokinetics, safety, and efficacy to bolster regulatory submissions.

Bioanalytical testing services can be classified into three broad categories including application, type, and service. Based on application, these services are divided into neurology, oncology, infectious disease,  cardiology,  gastroenterology, and other applications. Based on test type, bioanalytical testing services are segmented into pharmacokinetics, pharmacodynamics, bioavailability, bioequivalence, and others. Whereas, in terms of service, it is divided into quantitative immunoassays, immunochemistry, cell-based neutralization assays, discovery phase bioanalysis, LCMS method development, LCMS sample bioanalysis, GCP bioanalysis service, and protein and biomarker assays.

Thus, bioanalytical testing services encompass a wide range of techniques and analysis particularly in pharmaceutical and biotechnological research and development. These services are often provided by specialized bioanalytical contract service providers, contract research organizations (CROs), or analytical laboratories with expertise in biomolecule, metabolite, biosimilar, and peptide analysis. Some of the key bioanalytical testing services include:

  1. Pharmacokinetic (PK) Studies: Pharmacokinetic (PK) studies, as a form of bioanalytical service, evaluate the absorption, distribution, metabolism, and excretion of a drug within the body across time.

  1. BA and BE Studies: Bioanalytical testing services encompass BA/BE studies, where bioavailability denotes the degree and speed at which the active component (drug or metabolite) enters the systemic circulation, reaching the intended site of action. Whereas, Bioequivalence is assessed by comparing the relative bioavailability of the innovator drug with that of the generic version.

  1. Metabolite Analysis and Identification: Evaluating the metabolite patterns of drug candidates during preclinical and clinical stages is an essential part of bioanalytical testing services.

  1. Toxicokinetic (TK) Studies: TK is closely related to PK and is a part of bioanalytical testing services that evaluate the absorption, distribution, metabolism, and excretion of toxic drug substances in the body to understand their toxicological profiles.

  1. Immunoassay Profiling: Bioanalytical testing services include immunogenicity assays that detect and quantify the presence of antibodies generated in response to the administration of biological drugs.

  1. Biomarker Analysis: Biomarker analysis is a key element of bioanalytical testing that involves the measurement of specific molecules or indicators in biological samples to assess disease status, predict treatment response, or monitor disease progression.

  1. Bioanalytical Method Development and Validation: It includes quantifying drugs, metabolites, and biomarkers in biological samples according to regulatory guidelines.

  1. Preclinical and Clinical Assistance: Bioanalytical testing services also support early preclinical and clinical studies by providing analytical support for evaluating the safety, efficacy, and pharmacokinetics (PK) of drug candidates.

Therefore, CRO for bioanalytical services or bioanalytical CRO offers bioanalytical testing services, analytical and bioanalytical contract solutions, and other preclinical and clinical bioanalytical services. These bioanalytical contract laboratories and bioanalytical contract research organizations have sophisticated technologies for providing bioanalytical contract services for biomarker, biosimilar, protein, and peptide analysis for the successful drug development.

Q3. What are some emerging trends and technologies in bioanalytical services?

Biologics, or biological therapeutics, are a class of drugs derived from and purified using living cell cultures or blood. These are used to treat a broad range of diseases and continue to be the gold standard for many medical conditions. Due to their larger and more intricate molecular structure, biologics can offer precise and personalized treatments, potentially resulting in fewer side effects and safety concerns.

Pharmaceutical companies increasingly require diverse bioanalytical services to guarantee the safety and effectiveness of biological molecules, compounds, and biomarkers. Over the past few decades, there has been a growing emphasis on the validation of bioanalytical methods to ensure the reliability of pharmacokinetic (PK) data.

Certain bioanalytical contract research organizations offer bioanalytical testing, bioanalytical validation, and bioanalytical development services along with other bioanalytical solutions. These bioanalytical services are crucial in various fields including pharmaceuticals, biotechnology, and environmental science. Several emerging trends and technologies are shaping the landscape of bioanalytical services including:

  1. High-Throughput Screening (HTS): HTS rapidly screens large compound libraries for drug discovery, toxicity testing, and biomarker identification. Automation and robotics advances have boosted bioanalytical service efficiency.

  1. Multi-omics Technologies: Omics approaches, including genomics, metabolomics, proteomics, and transcriptomics, offer comprehensive insights into biological systems and provide drug response accuracy in bioanalytical services.

  1. Mass Spectrometry Technique: Advancements in MS techniques find applications in various areas of bioanalytical services such as metabolite profiling, proteomics, lipidomics, and drug metabolism studies.

  1. Second-Generation Sequencing: Second or next-generation sequencing (NGS) in bioanalytical services is used for genome sequencing, transcriptome analysis, epigenetics, and microbiome profiling.

  1. Microfabricated Devices: Microfabricated devices facilitate miniaturization, automation, and integration of bioanalytical assays and offer faster bioanalysis with reduced sample volumes.

  1. Imaging Techniques: Advanced imaging techniques such as super-resolution microscopy, HCS systems, and multiphoton microscopy enable visualization and bioanalysis of biological processes at the cellular and subcellular levels.

  1. Artificial Intelligence and Data Analytics: AI and machine learning technologies improve data interpretation and expedite the discovery process of bioanalytical services.

  1. Genome Engineering Technologies: CRISPR/Cas9 and other genome editing technologies allow improved bioanalysis and precise control over gene expression and aid in the creation of innovative therapeutics.

  1. Innovations in Biomarker Discovery and Validation: Bioanalytical services play a crucial role in identifying and validating biomarkers for disease diagnosis, prognosis, treatment monitoring, and their contribution to precision medicine.

These emerging trends and technologies are reshaping the capabilities of bioanalytical services, driving innovation, and accelerating scientific discoveries in various fields. The bioanalytical contract laboratories or CRO for bioanalytical services are equipped with specialized expertise and offer contract bioanalytical services, bioanalytical development services, clinical bioanalytical services, and bioanalytical testing support services for compound, metabolite, biosimilar, biomarker analysis, and peptide analysis.

Q4. Which are the leading CROs offering contract bioanalytical services?

Recently, contract bioanalytical services CRO or bioanalytical contract laboratories have gained importance because of increased R&D costs, requirements for special competencies, and analytical and bioanalytical laboratory services they offer. Specialized expertise of contract research organizations has been increasingly relying on bioanalytical testing services for both small and large molecules. Due to this reason, there has been a surge in outsourcing bioanalysis services to bioanalytical CROs.

Various contract research organizations (CROs) can offer bioanalytical contract services such as bioanalytical method development and validation, bioanalysis testing, bioanalytical development, etc. These are also known as CRO for bioanalytical services or bioanalytical CROs that might also offer clinical bioanalysis or clinical bioanalytical services for biological micro and macromolecules.

The market for contract bioanalytical services is constantly expanding. Several bioanalytical contract research organizations are providing comparable pharmaceutical analysis services. These bioanalytical CROs and CDMOs might have years of experience in bioanalysis testing, bioanalytical method validation, and method transfer, along with analytical method validation services. Some of the top bioanalytical contract service providers offering analytical and bioanalytical contract solutions and capabilities are explained below:

FumoPrep: FumoPrep offers analytical and bioanalytical contract solutions such as analytical method development, analytical method validation, bioanalytical development, and bioanalytical testing services for the determination of the metabolites from the body. Its bioanalytical CRO services also include bioanalytical method development and validation and bioanalytical testing support services in the fields of non-clinical dose formulations and bioanalysis.

Bora Pharmaceuticals: Bora offers contract bioanalytical services for biologics including bioanalysis testing, bioanalytical development, bioanalytical method validation, and clinical bioanalysis. It provides full-range of pharmaceutical analysis services from tox to pre-clinical and clinical development for drug formulations.

Quantys: Quantys is a CRO for bioanalytical services that provides bioanalytical solutions such as bioequivalence testing, bioanalytical method validation, and other clinical bioanalytical services. Its bioanalytical CRO services also include clinical bioanalysis and bioanalysis testing support services along with in-vitro and in-vivo correlation (IVIVC) studies, drug-drug interactions, steady state, and dose-response.

Quotient Sciences: Quotient Sciences offers pharmaceutical analysis services and has expertise in bioanalysis services, including bioanalytical assay development, validation and application, method transfer, high-resolution mass spec, and metabolite identification. It also provides analytical services such as analytical method development and analytical method validation apart from bioanalytical testing services.

Piramal: Piramal offers contract bioanalytical services along with analytical services such as bioanalytical and analytical method development, method validation, and method transfer. It also provides bioanalytical development services and other bioanalytical solutions for small molecules (non-GLP).

BioAgilytix: BioAgilytix is a CRO for bioanalytical services that provide biomarkers & cell-based assay services supporting all phases of drug development. Its bioanalytical CRO services include bioanalysis and bioanalytical testing services for large molecules.